JPMorgan Chase & Co’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.09B Buy
26,773,487
+4,811,521
+22% +$376M 0.14% 140
2025
Q1
$1.59B Buy
21,961,966
+7,110,139
+48% +$515M 0.12% 169
2024
Q4
$1.1B Buy
14,851,827
+6,385,779
+75% +$473M 0.08% 212
2024
Q3
$559M Sell
8,466,048
-212,869
-2% -$14M 0.04% 339
2024
Q2
$802M Sell
8,678,917
-922,139
-10% -$85.2M 0.07% 250
2024
Q1
$917M Buy
9,601,056
+1,770,391
+23% +$169M 0.08% 232
2023
Q4
$597M Buy
7,830,665
+4,332,955
+124% +$330M 0.06% 293
2023
Q3
$242M Buy
3,497,710
+317,229
+10% +$22M 0.03% 472
2023
Q2
$300M Buy
3,180,481
+767,847
+32% +$72.4M 0.03% 426
2023
Q1
$200M Buy
2,412,634
+587,461
+32% +$48.6M 0.02% 510
2022
Q4
$136M Sell
1,825,173
-196,581
-10% -$14.7M 0.02% 605
2022
Q3
$167M Buy
2,021,754
+50,418
+3% +$4.17M 0.02% 508
2022
Q2
$187M Buy
1,971,336
+671,264
+52% +$63.8M 0.03% 497
2022
Q1
$153M Buy
1,300,072
+199,094
+18% +$23.4M 0.02% 624
2021
Q4
$143M Sell
1,100,978
-10,693
-1% -$1.39M 0.02% 660
2021
Q3
$126M Sell
1,111,671
-41,284
-4% -$4.67M 0.02% 717
2021
Q2
$119M Sell
1,152,955
-664,028
-37% -$68.8M 0.01% 764
2021
Q1
$152M Buy
1,816,983
+60,439
+3% +$5.06M 0.02% 625
2020
Q4
$160M Buy
1,756,544
+38,508
+2% +$3.51M 0.02% 569
2020
Q3
$135M Buy
1,718,036
+298,153
+21% +$23.3M 0.02% 555
2020
Q2
$98.1M Sell
1,419,883
-1,013,537
-42% -$70M 0.02% 629
2020
Q1
$153M Buy
2,433,420
+1,371,828
+129% +$86.3M 0.04% 428
2019
Q4
$82.6M Buy
1,061,592
+76,857
+8% +$5.98M 0.02% 680
2019
Q3
$72.2M Sell
984,735
-243,603
-20% -$17.9M 0.01% 724
2019
Q2
$75.9M Sell
1,228,338
-1,017,993
-45% -$62.9M 0.01% 715
2019
Q1
$143M Buy
2,246,331
+23,025
+1% +$1.47M 0.03% 497
2018
Q4
$114M Buy
2,223,306
+17,025
+0.8% +$869K 0.03% 535
2018
Q3
$128M Sell
2,206,281
-158,907
-7% -$9.22M 0.02% 549
2018
Q2
$115M Buy
2,365,188
+649,779
+38% +$31.5M 0.02% 558
2018
Q1
$79.8M Sell
1,715,409
-195,768
-10% -$9.1M 0.02% 678
2017
Q4
$71.8M Buy
1,911,177
+217,986
+13% +$8.19M 0.02% 728
2017
Q3
$61.4M Buy
1,693,191
+100,041
+6% +$3.63M 0.01% 756
2017
Q2
$62.8M Sell
1,593,150
-24,363
-2% -$960K 0.01% 750
2017
Q1
$50.7M Sell
1,617,513
-397,518
-20% -$12.5M 0.01% 850
2016
Q4
$62.9M Sell
2,015,031
-688,455
-25% -$21.5M 0.02% 707
2016
Q3
$109M Sell
2,703,486
-555,282
-17% -$22.3M 0.03% 492
2016
Q2
$108M Buy
3,258,768
+238,431
+8% +$7.93M 0.03% 491
2016
Q1
$88.8M Buy
3,020,337
+412,374
+16% +$12.1M 0.02% 528
2015
Q4
$68.7M Buy
2,607,963
+90,897
+4% +$2.39M 0.02% 632
2015
Q3
$59.6M Sell
2,517,066
-17,856
-0.7% -$423K 0.02% 665
2015
Q2
$60.2M Buy
2,534,922
+428,052
+20% +$10.2M 0.01% 749
2015
Q1
$50M Sell
2,106,870
-615,546
-23% -$14.6M 0.01% 840
2014
Q4
$57.8M Sell
2,722,416
-1,224,084
-31% -$26M 0.01% 800
2014
Q3
$67.2M Buy
3,946,500
+3,195,300
+425% +$54.4M 0.02% 723
2014
Q2
$10.7M Sell
751,200
-1,758,990
-70% -$25.2M ﹤0.01% 1666
2014
Q1
$31M Buy
2,510,190
+955,068
+61% +$11.8M 0.01% 1054
2013
Q4
$17M Sell
1,555,122
-465,192
-23% -$5.1M ﹤0.01% 1340
2013
Q3
$23.4M Sell
2,020,314
-11,868
-0.6% -$138K 0.01% 1172
2013
Q2
$22.8M Buy
+2,032,182
New +$22.8M 0.01% 1102